4//SEC Filing
Zauderer Maurice 4
Accession 0001062993-24-019265
CIK 0001205922other
Filed
Nov 17, 7:00 PM ET
Accepted
Nov 18, 4:05 PM ET
Size
18.3 KB
Accession
0001062993-24-019265
Insider Transaction Report
Form 4
VACCINEX, INC.VCNX
Vaccinex (Rochester), L.L.C.
10% Owner
Transactions
- Award
Common Stock
2024-11-14$3.25/sh+46,153$149,997→ 297,941 total(indirect: By Vaccinex (Rochester), L.L.C.)
Holdings
- 15
Stock Option (Right to Buy)
Exercise: $1491.00Exp: 2025-12-23→ Common Stock (15 underlying) - 135
Stock Option (Right to Buy)
Exercise: $1402.80Exp: 2025-02-24→ Common Stock (135 underlying) - 1,011(indirect: By Trust)
Common Stock
- 170,475(indirect: By Vaccinex (Rochester), L.L.C.)
Warrant (Right to Buy)
Exercise: $5.64From: 2024-09-18Exp: 2029-09-18→ Common Stock (170,475 underlying) - 1,016(indirect: By Trust)
Common Stock
- 1,877
Stock Option (Right to Buy)
Exercise: $8.21Exp: 2034-03-21→ Common Stock (1,877 underlying) - 266
Stock Option (Right to Buy)
Exercise: $92.26Exp: 2028-03-30→ Common Stock (266 underlying) - 133
Stock Option (Right to Buy)
Exercise: $270.90Exp: 2032-04-01→ Common Stock (133 underlying) - 1,580
Common Stock
- 66
Stock Option (Right to Buy)
Exercise: $615.30Exp: 2031-04-02→ Common Stock (66 underlying)
Zauderer Maurice
DirectorPresident and CEO10% Owner
Transactions
- Award
Common Stock
2024-11-14$3.25/sh+46,153$149,997→ 297,941 total(indirect: By Vaccinex (Rochester), L.L.C.)
Holdings
- 66
Stock Option (Right to Buy)
Exercise: $615.30Exp: 2031-04-02→ Common Stock (66 underlying) - 266
Stock Option (Right to Buy)
Exercise: $92.26Exp: 2028-03-30→ Common Stock (266 underlying) - 133
Stock Option (Right to Buy)
Exercise: $270.90Exp: 2032-04-01→ Common Stock (133 underlying) - 15
Stock Option (Right to Buy)
Exercise: $1491.00Exp: 2025-12-23→ Common Stock (15 underlying) - 1,011(indirect: By Trust)
Common Stock
- 1,580
Common Stock
- 1,016(indirect: By Trust)
Common Stock
- 135
Stock Option (Right to Buy)
Exercise: $1402.80Exp: 2025-02-24→ Common Stock (135 underlying) - 170,475(indirect: By Vaccinex (Rochester), L.L.C.)
Warrant (Right to Buy)
Exercise: $5.64From: 2024-09-18Exp: 2029-09-18→ Common Stock (170,475 underlying) - 1,877
Stock Option (Right to Buy)
Exercise: $8.21Exp: 2034-03-21→ Common Stock (1,877 underlying)
Footnotes (7)
- [F1]Dr. Zauderer exercises voting control over shares held by this trust and disclaims beneficial ownership over these shares except to the extent of his pecuniary interest therein.
- [F2]Dr. Zauderer is the president and a majority owner of Vaccinex (Rochester), L.L.C. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
- [F3]Exercisable in full as of the date of this report.
- [F4]This option vests one-fourth on each of the first four anniversaries of the April 2, 2021 grant date, except as otherwise provided in the award notice.
- [F5]This option vests one-fourth on each of the first four anniversaries of the April 1, 2022 grant date, except as otherwise provided in the award notice.
- [F6]This option vests one-fourth on each of the first four anniversaries of the March 31, 2023 grant date, except as otherwise provided in the award notice.
- [F7]This option vests one-fourth on each of the first four anniversaries of the March 21, 2024 grant date, except as otherwise provided in the award notice.
Issuer
VACCINEX, INC.
CIK 0001205922
Entity typeother
Related Parties
1- filerCIK 0001747753
Filing Metadata
- Form type
- 4
- Filed
- Nov 17, 7:00 PM ET
- Accepted
- Nov 18, 4:05 PM ET
- Size
- 18.3 KB